Orbimed Advisors reported a 12.2% stake in Corvus Pharmaceuticals CRVS · 9,785,423 sh · amendment

Trade details

Type: 5% stake report
Report: 13D · amendment
Stake: 12.2%
Last report: 13.8% · filed 25/05/01
Shares held: 9,785,423 sh
Class: Common stock, par value $0.0001 per share (the "Shares").
Stock: Corvus Pharmaceuticals CRVS
Holder: Orbimed Advisors
Event date: 25/05/12
Filed: 25/05/14

12.2% stake · −1.6pp from the last report

Stake: 12.2%
Last report: 13.8%
Since last report: −1.6pp

Corvus Pharmaceuticals trades, last 26 weeks

What else happened in Corvus Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/04/12~25/06/11

Orbimed Advisors's other 5% stake reports

Orbimed Advisors
5% stakeElectra Therapeutics
5% stake
Electra Therapeutics
ETRA
11% stake
6,885,170 sh
11% stake
Filed 09/25
Orbimed Advisors
5% stakeBraveheart Bio
5% stake
Braveheart Bio
BRVE
13.5% stake
12,175,159 sh
13.5% stake
Filed 09/10
Orbimed Advisors
5% stakeBraveheart Bio
5% stake
Braveheart Bio
BRVE
17.2% stake
12,175,159 sh
17.2% stake
Filed 08/18
Orbimed Advisors
5% stakeBlossomHill Therapeutics
5% stake
BlossomHill Therapeutics
BLSM
8.9% stake
2,714,279 sh
8.9% stake
Filed 08/18
Orbimed Advisors
5% stakeWhitehawk Therapeutics
5% stake
Whitehawk Therapeutics
WHWK
7.3% stake
3,934,296 sh
7.3% stake
Filed 08/14